---
title: "Vaccine Effectiveness Methods"
subtitle: "Statistical methods for estimating vaccine protection from observational data"
page-layout: article
title-block-banner: "#8e44ad"
title-block-banner-color: white
---

```{=html}
<style>
.highlight-card {
  border-left: 4px solid #8e44ad;
  background: linear-gradient(135deg, #f8f9fa 0%, #f3e5f5 100%);
  padding: 1.5rem;
  margin: 1.5rem 0;
  border-radius: 0 8px 8px 0;
}

.project-card {
  background: white;
  border: 1px solid #dee2e6;
  border-radius: 12px;
  padding: 1.5rem;
  margin: 1rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.08);
  transition: transform 0.2s ease, box-shadow 0.2s ease;
}

.project-card:hover {
  transform: translateY(-2px);
  box-shadow: 0 4px 16px rgba(0,0,0,0.12);
}

.project-card h3 {
  color: #2c3e50;
  margin-bottom: 0.75rem;
  font-size: 1.25rem;
}

.pub-item {
  background: #f8f9fa;
  padding: 1rem 1.25rem;
  margin: 0.75rem 0;
  border-radius: 8px;
  border-left: 3px solid #8e44ad;
}

.pub-item:hover {
  background: #e9ecef;
}

.section-header {
  border-bottom: 2px solid #8e44ad;
  padding-bottom: 0.5rem;
  margin-top: 2.5rem;
  margin-bottom: 1.5rem;
}

.featured-image {
  border-radius: 12px;
  box-shadow: 0 4px 20px rgba(0,0,0,0.15);
  margin: 2rem 0;
}

.back-link {
  display: inline-flex;
  align-items: center;
  gap: 0.5rem;
  color: #6c757d;
  text-decoration: none;
  font-weight: 500;
  margin-top: 2rem;
  padding: 0.5rem 1rem;
  border-radius: 6px;
  transition: all 0.2s ease;
}

.back-link:hover {
  background: #f8f9fa;
  color: #2c3e50;
}

.method-grid {
  display: grid;
  grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
  gap: 1rem;
  margin: 1.5rem 0;
}

.method-item {
  background: #f3e5f5;
  padding: 1.25rem;
  border-radius: 10px;
  border: 1px solid #e1bee7;
}

.method-item h4 {
  color: #8e44ad;
  margin: 0 0 0.5rem 0;
  font-size: 1rem;
}

.method-item p {
  margin: 0;
  font-size: 0.9rem;
  color: #555;
}

.vaccine-tags {
  display: flex;
  flex-wrap: wrap;
  gap: 0.5rem;
  margin-top: 1rem;
}

.vaccine-tag {
  background: #8e44ad;
  color: white;
  padding: 0.35rem 0.75rem;
  border-radius: 20px;
  font-size: 0.85rem;
  font-weight: 500;
}
</style>
```

::: {.highlight-card}
**Focus:** Developing and evaluating statistical methods that provide reliable vaccine effectiveness estimates while accounting for biases in observational study designs.
:::

![](../images/placeholder_ve.jpg){.featured-image fig-align="center" width="100%"}

## Waning Protection {.section-header}

::: {.project-card}
### Waning Vaccine Effectiveness

The WAVE project develops and evaluates statistical methods for assessing how vaccine-induced protection changes over time. Key objectives include distinguishing true immunity decline from apparent waning due to changes in pathogen or population, identifying individual determinants of protection decline, and applying methods across multiple vaccines — including pertussis, influenza, COVID-19, and rotavirus.

::: {.pub-item}
Haber, M., *et al*. Comparing statistical methods for detecting and estimating waning efficacy of rotavirus vaccines in developing countries. *Hum Vaccin Immunother.* 2021. [Read paper →](https://doi.org/10.1080/21645515.2021.1968738)
:::

::: {.pub-item}
Chen, D., Cowling, B. J., **Ainslie, K. E. C.**, *et al*. Association of COVID-19 vaccination with duration of hospitalisation in older adults in Hong Kong. *Vaccine* 2024. [Read paper →](https://doi.org/10.1016/j.vaccine.2024.02.074)
:::
:::

## Influenza {.section-header}

::: {.project-card}
### Bias in Observational Studies

Statistical and modelling approaches to identify and account for bias in observational VE studies. This includes evaluating sources of bias in common study designs, developing methods to estimate VE against both susceptibility and onward transmission, and extending this work from influenza to COVID-19 contexts.

::: {.pub-item}
**Ainslie, K. E. C.**, *et al*. A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates. *Am J Epidemiol.* 2018. [Read paper →](https://doi.org/10.1093/aje/kwy240)
:::

::: {.pub-item}
**Ainslie, K. E. C.**, *et al*. Challenges in estimating influenza vaccine effectiveness. *Expert Rev Vaccines.* 2019. [Read paper →](https://doi.org/10.1080/14760584.2019.1622419)
:::

::: {.pub-item}
**Ainslie, K. E. C.**, *et al*. Maximum likelihood estimation of influenza vaccine effectiveness against transmission. *Stat Med.* 2017. [Read paper →](https://doi.org/10.1002/sim.7558)
:::

::: {.pub-item}
**Ainslie, K. E. C.**, Haber, M., Orenstein, W. A. Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during multiple seasons. *Vaccine* 2019. [Read paper →](https://doi.org/10.1016/j.vaccine.2019.02.036)
:::

::: {.pub-item}
**Ainslie, K. E. C.**, Shi, M., Haber, M., Orenstein, W. A. On the bias of estimates of influenza vaccine effectiveness from test-negative studies. *Vaccine* 2017. [Read paper →](https://doi.org/10.1016/j.vaccine.2017.10.107)
:::

::: {.pub-item}
Shi, M., An, Q., **Ainslie, K. E. C.**, *et al*. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness. *BMC Infect Dis.* 2017. [Read paper →](https://doi.org/10.1186/s12879-017-2838-2)
:::

::: {.pub-item}
Sullivan, S. G., Khvorov, A., Huang, X., **Ainslie, K. E. C.**, *et al*. The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness. *npj Vaccines* 2023. [Read paper →](https://doi.org/10.1038/s41541-023-00716-9)
:::

::: {.pub-item}
Tsang, T. K., *et al*. Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies. *Am J Epidemiol.* 2024. [Read paper →](https://doi.org/10.1093/aje/kwae142)
:::
:::

::: {.project-card}
### Repeat Vaccination Effects

Individual-based stochastic modelling to investigate optimal influenza vaccination strategies in children, accounting for prior vaccination history, antigenic dynamics, and long-term immune imprinting.

::: {.pub-item}
**Ainslie, K. E. C.** and Riley, S. Is annual vaccination best? A modelling study of influenza vaccination strategies in children. *Vaccine* 2022. [Read paper →](https://doi.org/10.1016/j.vaccine.2022.03.065)
:::

**Related software:** [morevac](https://github.com/kylieainslie/morevac){.btn .btn-primary .btn-sm style="background-color: #8e44ad; border-color: #8e44ad;"}
:::

<a href="../research.html" class="back-link">← Back to Research</a>
